Similar articles

• [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].

  Mitsuya H. Mitsuya H. Nihon Rinsho. 1991 Sep;49(9):2062-9. Nihon Rinsho. 1991. PMID: 1720470 Japanese. No abstract available.
• [HIV drug resistance and its genetic basis].

  Tsuchie H, Sakamoto T, Kurimura T. Tsuchie H, et al. Nihon Rinsho. 1993 Sep;51 Suppl:610-4. Nihon Rinsho. 1993. PMID: 7505854 Japanese. No abstract available.
• Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.

  Chow YK, Hirsch MS, Merrill DP, Bechtel LJ, Eron JJ, Kaplan JC, D'Aquila RT. Chow YK, et al. Nature. 1993 Feb 18;361(6413):650-4. doi: 10.1038/361650a0. Nature. 1993. PMID: 7679778
• Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.

  Erice A, Balfour HH Jr. Erice A, et al. Clin Infect Dis. 1994 Feb;18(2):149-56. doi: 10.1093/clinids/18.2.149. Clin Infect Dis. 1994. PMID: 7512829 Review. No abstract available.
• HIV-1 drug resistance. Molecular pathogenesis and laboratory monitoring.

  D'Aquila RT. D'Aquila RT. Clin Lab Med. 1994 Jun;14(2):393-422. Clin Lab Med. 1994. PMID: 7523021 Review.